Sirio Secures TGA GMP Certification to Support Strategic Growth in Australia

SIRIO Pharma (China) has announced that its Ma’anshan facility in China has been granted a Certificate of GMP (good manufacturing practice) Compliance by the Therapeutic Goods Administration (TGA) of Australia. The approval will support SIRIO’s expansion into the rapidly growing Australian market, providing both local and international brands with greater product development and manufacturing options. SIRIO ...